论文部分内容阅读
目的观察骨化三醇治疗甲状腺功能亢进性骨质疏松症的临床疗效。方法选取2015年2月至2016年3月甲状腺功能亢进性骨质疏松症患者96例,随机分为两组,每组48例。研究组采用骨化三醇治疗,对照组则采用抗甲状腺药物联合阿仑膦酸钠片治疗,比较两组治疗效果。结果治疗10周后,研究组总有效率高于对照组,研究组疼痛评分低于对照组,差异有统计学意义(P<0.05)。结论骨化三醇治疗甲状腺功能亢进性骨质疏松症临床效果好,可以有效抑制甲状腺细胞的增生。
Objective To observe the clinical effect of calcitriol in the treatment of hyperthyroidism osteoporosis. Methods From February 2015 to March 2016, 96 patients with hyperthyroidism osteoporosis were randomly divided into two groups (n = 48 in each group). The study group treated with calcitriol, the control group was treated with anti-thyroid drugs and alendronate sodium tablets, the treatment effect was compared between the two groups. Results After 10 weeks of treatment, the total effective rate of the study group was higher than that of the control group, and the pain score of the study group was lower than that of the control group (P <0.05). Conclusion calcitriol treatment of hyperthyroidism osteoporosis clinical effect is good, can effectively inhibit the proliferation of thyroid cells.